Abstract

TDP-43 (43-kDa TAR DNA-binding domain protein) is a major constituent of ubiquitin-positive cytoplasmic aggregates present in neurons of patients with fronto-temporal lobular dementia and amyotrophic lateral sclerosis (ALS). The pathologic significance of TDP-43 aggregation is not known; however, dominant mutations in TDP-43 cause a subset of ALS cases, suggesting that misfolding and/or altered trafficking of TDP-43 is relevant to the disease process. Here, we show that the presenilin-binding protein ubiquilin 1 (UBQLN) plays a role in TDP-43 aggregation. TDP-43 interacted with UBQLN both in yeast and in vitro, and the carboxyl-terminal ubiquitin-associated domain of UBQLN was both necessary and sufficient for binding to polyubiquitylated forms of TDP-43. Overexpression of UBQLN recruited TDP-43 to detergent-resistant cytoplasmic aggregates that colocalized with the autophagosomal marker, LC3. UBQLN-dependent aggregation required the UBQLN UBA domain, was mediated by non-overlapping regions of TDP-43, and was abrogated by a mutation in UBQLN previously linked to Alzheimer disease. Four ALS-associated alleles of TDP-43 also coaggregated with UBQLN, and the extent of aggregation correlated with in vitro UBQLN binding affinity. Our findings suggest that UBQLN is a polyubiquitin-TDP-43 cochaperone that mediates the autophagosomal delivery and/or proteasome targeting of TDP-43 aggregates.

Highlights

  • 10% of amyotrophic lateral sclerosis (ALS) cases, termed familial ALS, have a clear genetic link

  • The significance of TDP-43 aggregates has been validated by several recent studies demonstrating that mutations in the TARDBP gene locus encoding TDP-43 cause a subset of familial ALS (fALS) and sALS cases [24, 25]

  • Considered together, the current findings suggest that the molecular neuropathogenesis of sALS with TDP-43 aggregates may be conceptually similar to other neurodegenerative proteinopathies, including Alzheimer disease (AD), Parkinson disease, and Huntington disease [26]

Read more

Summary

EXPERIMENTAL PROCEDURES

Yeast Two-hybrid Screening and DNA Construction—We screened a human fetal brain cDNA library (MatchmakerTM GAL4 Two-Hybrid System, Clontech) using a full-length TDP-43 cDNA cloned into XmaI and BamHI sites of the bait vector pGBKT7 (Clontech). The open reading frame of human UBQLN (amino acids 1–589) was PCR amplified as mentioned above and subcloned into pCMV-Myc vector for expression in the mammalian tissue culture system. Human UBQLN and its truncation mutants were PCR amplified and subcloned into pGEX-5X-2 for glutathione S-transferase (GST) fusion protein expression. Fortyeight hours after transfection, cell pellets were extracted with lysis buffer and 500 ␮g of each clarified extract was incubated with GST or GST-UBQLN fusion proteins (20 ␮g) that had been prebound to GSH-agarose beads. The cells were lysed in a solution containing 0.15 M Tris-HCl, pH 6.7, 5% SDS, and 30% glycerol, and incubated at solved by 10% SDS-PAGE, transferred onto polyvinylidene difluoride membrane, and blotted using ␣-HA antibodies to detect affinity purified HA-TDP-43.

C Endog -TDP-43
D HA-TDP-43
RESULTS
TDP-43 N-del1 N-del2
Findings
B TDP-43
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call